Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07130669) titled 'FACE Phase II (a Stage II Trial)' on Aug. 5.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: Double (Participant, Investigator).
Primary Sponsor: Stanford University
Condition:
MCI
Subjective Cognitive Decline (SCD)
Mild Behavioral Impairment
Intervention:
Behavioral: Cognitive Remediation
Recruitment Status: Not recruiting
Phase: Phase 1/Phase 2
Date of First Enrollment: October 31, 2025
Target Sample Size: 80
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/ct2/sho...